We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Snap Officer Murphy Plans Second 2M-Share Sale in Nov 2026

Robert C. Murphy, an officer and director of Snap Inc, filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 2,000,000 shares of Snap common stock through Wells Fargo Clearing Services on behalf of The Wayne Manor Revocable Trust.

Manish Choudhary | 09 November 2026

Diamond Receives 17,123 RSUs in Hyperliquid Strategies

Director Robert E. Diamond Jr. filed a Form 4 on November 9, 2026, disclosing the acquisition of 17,123 restricted stock units in Hyperliquid Strategies Inc (NASDAQ:PURR) on November 5, 2026.

Manish Choudhary | 09 November 2026

Peter Kampian Files Form 3 as New Greenlane Director

Peter Kampian, a newly appointed director of Greenlane Holdings, Inc., filed an initial statement of beneficial ownership with the SEC on November 9, 2026, reporting no securities beneficially owned as of the event date of October 27, 2026.

Manish Choudhary | 09 November 2026

Kyle Clark Plans to Sell 10,000 BETA Technologies Shares Nov. 9

Kyle Clark, an officer of BETA Technologies, Inc., filed a Form 144 notice of proposed sale on November 9, 2026, disclosing plans to sell 10,000 shares of common stock on the NYSE under Rule 144 of the Securities Act of 1933.

Nitish Kishor | 09 November 2026

Wilson Martin Sells 53,389 Rocket Pharma Shares at $2.394

Martin Wilson, General Counsel of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), filed a Form 4 on November 9, 2026, disclosing the sale of 53,389 shares of common stock on November 5, 2026, to cover tax withholding obligations related to vesting restricted stock units.

Anjali Anand | 09 November 2026

Teva EVP Richard Daniell Plans Sale of 25,000 Ordinary Shares

Teva Pharmaceutical Industries Ltd's Executive Vice President of European Commercial, Richard Daniell, filed a Form 144 notice of proposed sale of 25,000 ordinary shares on November 9, 2026, with the sale to be executed through Citigroup Global Markets Inc. on NYSE.

Aakashdeep | 09 November 2026

Gartner Officer Genovese Plans Sale of 524 Shares

Gartner, Inc. officer Yvonne Genovese filed a Form 144 notice of proposed sale of 524 shares of Gartner common stock, submitted on November 9, 2026.

Aakashdeep | 09 November 2026

Awilhelmsen AS Plans 500,000-Share Royal Caribbean Sale

Awilhelmsen AS, listed as a director-related entity of Royal Caribbean Cruises Ltd, filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 500,000 shares of Royal Caribbean common stock on the NYSE.

Aditi Sarkar | 09 November 2026

Accel Entertainment CSO Arntzen Plans 10,000-Share Sale

Accel Entertainment, Inc. Chief Strategy Officer Steven W. Arntzen filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 10,000 shares of common stock through UBS Financial Services, Inc.

Manish Choudhary | 09 November 2026

Kathleen Pitre Files to Sell 30,245 Ball Corp Shares

Former Ball Corporation officer Kathleen E. Pitre filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 30,245 shares of Ball Corporation common stock with an aggregate market value of $2,037,705.46.

Vinay Lochav | 09 November 2026
Support

Hi! How can we help you today?

Loading…